Moneycontrol PRO
HomeNewsBusinessMarketsClosing Bell: Nifty ends below 11,450, Sensex falls 100 points; bank stocks outperform
Live now
auto refresh

Closing Bell: Nifty ends below 11,450, Sensex falls 100 points; bank stocks outperform

The Sensex was down 100.53 points at 38,132.88, while Nifty was down 38.30 points at 11,445.

March 27, 2019 / 15:35 IST
  • Moneycontrol.com
  • IndexPricesChangeChange%
    Sensex83,938.71-465.75 -0.55%
    Nifty 5025,722.10-155.75 -0.60%
    Nifty Bank57,776.35-254.75 -0.44%
    Nifty 50 25,722.10 -155.75 (-0.60%)
    Fri, Oct 31, 2025
    Biggest GainerPricesChangeChange%
    Bharat Elec426.1016.20 +3.95%
    Biggest LoserPricesChangeChange%
    Eternal317.75-11.60 -3.52%
    Best SectorPricesChangeChange%
    Nifty PSU Bank8184.35125.60 +1.56%
    Worst SectorPricesChangeChange%
    Nifty Metal10612.20-117.00 -1.09%


  • March 27, 2019 / 15:34 IST

    Market at close:

    It is weak closing for the benchmark indices on Wednesday after market erased all its morning gains in the later part of the day.

    The Sensex was down 100.53 points at 38,132.88, while Nifty was down 38.30 points at 11,445. About 1189 shares have advanced, 1524 shares declined, and 152 shares are unchanged.

    NTPC, HPCL, Tata Motors, Bharti Airtel and Eicher Motors were the top losers on the Nifty, while gainers include Yes Bank, IndusInd Bank, Indiabulls Housing, JSW Steel and SBI.

    Among the sectors, energy, auto, FMCG, infra, IT, metal and pharma remained under pressure, while some buying seen in the banking stock, with Nifty Bank ended above 30,000 level.

  • March 27, 2019 / 15:23 IST

    Lupin receives USFDA approval

    The company has received approval for its Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg, from the United States Food and Drug Administration (FDA) to market a generic version of Eli Lilly and Company’s Cialis Tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg.

  • March 27, 2019 / 15:16 IST

    Vedanta notifies gas discovery

    : Vedanta has notified the Management Committee, Directorate General of Hydrocarbons and Ministry of Petroleum and Natural Gas of an oil discovery in the second exploratory well H2, located in the block KG-OSN-2009/3, Krishna-Godavari Basin, East Coast of India.

  • March 27, 2019 / 15:01 IST

    Maruti Suzuki board approved reappointment of Kenichi Ayukawa as managing director and CEO of the company for a period of 3 years w.e.f. April 1, 2019.

  • March 27, 2019 / 14:50 IST

    Subex gets contract

    Subex has been awarded a six-year deal with VodafoneZiggo to deploy its ROC Partner Settlement and Route Optimization Solutions.

  • March 27, 2019 / 14:42 IST

    Image Source:Bloomberg

  • March 27, 2019 / 14:31 IST

    Strides Pharma Science receives USFDA approval

    Strides Pharma Science has received USFDA approval for its greenfield oral dosage facility in Singapore.

  • March 27, 2019 / 14:11 IST

    Buzzing

    : Shares of UCO Bank gained 5 percent intraday on March 27 after a report said that the special payment mechanism for importing crude oil from Iran granted the state-run bank Rs 13,000-14,000 crore windfall.

  • March 27, 2019 / 14:02 IST
  • March 27, 2019 / 13:55 IST

    Market Update

    It is a sharp fall in the market on Wednesday afternoon with Nifty slipped below 11,450 level.

    The Sensex is down 136.11 points at 38097.30, while Nifty down 44.60 points at 11438.70.

  • March 27, 2019 / 13:44 IST

    Zydus Cadila announced the Day 1 launch of Tadalafil Tablets USP upon receiving the final approval from the USFDA for marketing the product in the strengths of 2.5 mg, 5 mg, 10 mg, and 20 mg.

  • March 27, 2019 / 13:33 IST

    CARE reaffirmed credit rating on the bank facilities of PNC Infratech subsidiary, PNC Bareilly Nainital Highways, as CARE BBB with stable outlook.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347